(MedPage Today) — Patients with type 2 diabetes who were treated with GLP-1 receptor agonists were less likely to develop peptic ulcer disease (PUD), a nationwide study found.
In an analysis of more than 65,000 patients, GLP-1 users had 44% lower…
Source link : https://www.medpagetoday.com/gastroenterology/pepticulcerdisease/117217
Author :
Publish date : 2025-08-29 14:08:00
Copyright for syndicated content belongs to the linked Source.
